BALCHEM CORPBCPC

Market cap
$5.2B
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net earnings3940455360569079808596105109128
Depreciation and amortization910103140464445465149525548
Stock compensation expense444577668811131617
Deferred income taxes0-0-0-11-3-7-29-5-4-5-6-8-11-7
Provision for credit losses-00-0-0000200000
Unrealized (gain) loss on foreign currency transactions and deferred compensation-------------1-0
Asset impairment charge and loss on disposal of assets-------------7-2
Change in fair value of contingent consideration liability-------------11-0
Accounts receivable38-38-111648-124214-7-6
Inventories324-7-3-50611-14218-1123
Prepaid expenses and other current assets00-01-1-00-2-031-24-0
Accounts payable and accrued expenses16-38-1618261-147-1649
Income taxes-34-131-301-62502-1
Other-001-0-0011-102-002
Net cash provided by operating activities455456---111119124150161139184182
Cash paid for acquisitions, net of cash acquired-----1111717141--366124
Capital expenditures and intangible assets acquired--------283437503836
Proceeds from sale of assets0-0000011200020
Proceeds from settlement of net investment hedge-------------3-
Investment in affiliates------------00
Net cash used in investing activities-7-14-8----43-32-156-35-35-416-35-60
Proceeds from revolving loan------------1826
Principal payments on revolving debt---50-544455769560103149146
Principal payments on acquired debt--------18--31--
Cash paid for financing costs-------1---1--
Principal payments on finance lease---------00000
Proceeds from stock options exercised429913710851473517
Dividends paid412-89111213151719212326
Repurchases of common stock022112212113353546
Net cash (used in) provided by financing activities-1-1016----69-7143-101-102247-153-134
Effect of exchange rate changes on cash---------04-4-62-3
Decrease in cash and cash equivalents--------111919-37-2-15